ALSO NOTED: Novartis, Schering-Plough to collaborate; China confirms new bird flu death;and much more...

> Novartis and Schering-Plough announced they will collaborate on a new, once-daily therapy for asthma. The new treatment will combined Schering-Plough's  Asmanex asthma drug with Novartis' medication indacaterol. Report

> China has confirmed its fourteenth death from the lethal H5N1 virus. The list also includes the first death from bird flu in 2003, which the country acknowledged only last week. Report

> GlaxoSmithKline and Shionogi have completed their first clinical trial of an experimental AIDS/HIV therapy that belongs to a new class of integrase inhibitors. Report

> MedImmune has responded to the FDA's request for more information regarding a new version of its flu vaccine that will only need to be stored in a refrigerator rather than a freezer. Report

> Savient Pharmaceuticals is buying back 10 million of its shares. Report

> China's Aida Pharmaceuticals, which is working in the field of gene therapy, has completed the acquisition of Shanghai Qiaer Bio-Technology. Release

And Finally… A federal advisory panel has suggested easing rules that have long prohibited researchers from using prisoners in drug trials. Article

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.